Related Experiment Videos
Unstable angina pectoris: comparison with the National Cooperative Study
The Annals of Thoracic Surgery
|October 1, 1982
Summary
Coronary artery bypass surgery for unstable angina showed significantly lower perioperative infarction and hospital mortality rates compared to previous studies. These improvements in outcomes are attributed to timely surgical intervention and advanced techniques.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Medicine
Background:
- Unstable angina pectoris (UAP) poses significant risks, with previous studies highlighting high complication rates.
- The National Cooperative Study established benchmarks for UAP treatment outcomes.
Purpose of the Study:
- To compare outcomes of coronary artery bypass surgery in patients with prolonged chest pain and transient ischemic changes against historical data.
- To evaluate the safety and efficacy of surgical intervention for unstable angina.
Main Methods:
- Retrospective comparison of 78 patients undergoing coronary artery bypass surgery with 288 patients from the National Cooperative Study on UAP.
- Analysis of clinical characteristics, vessel disease severity, left ventricular function, perioperative infarction, hospital mortality, and late outcomes.
Main Results:
- The current surgical series demonstrated significantly lower perioperative infarction (3.8% vs. 17%) and hospital mortality (1.2% vs. 2.0-3.0%) compared to the National Cooperative Study.
- Late myocardial infarction rates were also lower in the current series (3% at 43 months vs. 11-13% at 30 months).
- Actuarial survival was high at 95% at 42 months.
Conclusions:
- Immediate coronary artery bypass surgery after ruling out acute myocardial infarction, coupled with surgical advancements, leads to improved outcomes.
- Patient selection, including preserved left ventricular function and complete revascularization, contributes to reduced mortality and morbidity.
- This study suggests that timely surgical intervention is a safe and effective strategy for managing unstable angina pectoris.